The Fool , bad news yesterday with Rick Munarriz and good news today with Keith Speights same brokerage
same newsletter , amazing, they have no credibility left with the public
5 Numbers Rockwell Medical Investors Need to Know
By Keith Speights | More Articles
A couple more numbers
All five of these numbers point to a couple of other numbers that should interest investors. Sales of Triferic are projected to hit close to $250 million annually. That figure doesn't include other products sold by the company. Rockwell Medical's market cap currently stands around $500 million.
Rockwell's stock seems poised to go up considerably from current levels if Triferic gains FDA approval. Keep in mind that nothing's ever a certainty when it comes to the approval process. However, the drug's efficacy and safety profile look solid. The odds of approval should be pretty good. At this point, the numbers for Rockwell Medical seem to add up nicely. Less